131 related articles for article (PubMed ID: 35863998)
21. Hepatitis B virus DNA methylation and its potential role in chronic hepatitis B.
Low WF; Ngeow YF; Chook JB; Tee KK; Ong SK; Peh SC; Bong JJ; Mohamed R
Expert Rev Mol Med; 2022 Nov; 25():e11. PubMed ID: 36380484
[TBL] [Abstract][Full Text] [Related]
22. Association of Hepatitis B Virus Covalently Closed Circular DNA and Human APOBEC3B in Hepatitis B Virus-Related Hepatocellular Carcinoma.
Luo X; Huang Y; Chen Y; Tu Z; Hu J; Tavis JE; Huang A; Hu Y
PLoS One; 2016; 11(6):e0157708. PubMed ID: 27310677
[TBL] [Abstract][Full Text] [Related]
23. Among Patients with Undetectable Hepatitis B Surface Antigen and Hepatocellular Carcinoma, a High Proportion Has Integration of HBV DNA into Hepatocyte DNA and No Cirrhosis.
Wong DK; Cheng SCY; Mak LL; To EW; Lo RC; Cheung TT; Seto WK; Fung J; Man K; Lai CL; Yuen MF
Clin Gastroenterol Hepatol; 2020 Feb; 18(2):449-456. PubMed ID: 31252193
[TBL] [Abstract][Full Text] [Related]
24. Quantitation of hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) in the liver of HBV-infected patients by LightCycler real-time PCR.
Singh M; Dicaire A; Wakil AE; Luscombe C; Sacks SL
J Virol Methods; 2004 Jun; 118(2):159-67. PubMed ID: 15081611
[TBL] [Abstract][Full Text] [Related]
25. Validation of a sensitive and specific real-time PCR for detection and quantitation of hepatitis B virus covalently closed circular DNA in plasma of chronic hepatitis B patients.
Takkenberg RB; Zaaijer HL; Molenkamp R; Menting S; Terpstra V; Weegink CJ; Dijkgraaf MG; Jansen PL; Reesink HW; Beld MG
J Med Virol; 2009 Jun; 81(6):988-95. PubMed ID: 19382261
[TBL] [Abstract][Full Text] [Related]
26. Validation of a sensitive and specific real-time PCR for detection and quantitation of hepatitis B virus covalently closed circular DNA in plasma of chronic hepatitis B patients.
Takkenberg RB; Menting S; Beld MG
Methods Mol Biol; 2012; 903():113-28. PubMed ID: 22782814
[TBL] [Abstract][Full Text] [Related]
27. Clinical relevance of the study of hepatitis B virus covalently closed circular DNA.
Kumar R; Pérez-Del-Pulgar S; Testoni B; Lebossé F; Zoulim F
Liver Int; 2016 Jan; 36 Suppl 1():72-7. PubMed ID: 26725901
[TBL] [Abstract][Full Text] [Related]
28. HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma.
Sohn W; Paik YH; Kim JM; Kwon CH; Joh JW; Cho JY; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
Ann Surg Oncol; 2014 Jul; 21(7):2429-35. PubMed ID: 24619495
[TBL] [Abstract][Full Text] [Related]
29. Cell-Free Virus-Host Chimera DNA From Hepatitis B Virus Integration Sites as a Circulating Biomarker of Hepatocellular Cancer.
Li CL; Ho MC; Lin YY; Tzeng ST; Chen YJ; Pai HY; Wang YC; Chen CL; Lee YH; Chen DS; Yeh SH; Chen PJ
Hepatology; 2020 Dec; 72(6):2063-2076. PubMed ID: 32171027
[TBL] [Abstract][Full Text] [Related]
30. [A quantitative real time polymerase chain reaction for detection of HBV covalently closed circular DNA in livers of the HBV infected patients].
Wang MR; Qiu N; Lu SC; Xiu DR; Yu JG; Li T; Liu XE; Zhuang H
Zhonghua Liu Xing Bing Xue Za Zhi; 2011 May; 32(5):504-9. PubMed ID: 21569737
[TBL] [Abstract][Full Text] [Related]
31. Serum hepatitis B surface antigen correlates with tissue covalently closed circular DNA in patients with hepatitis B-associated hepatocellular carcinoma.
Wang Q; Luan W; Warren L; Fiel MI; Blank S; Kadri H; Tuvin D; Hiotis SP
J Med Virol; 2016 Feb; 88(2):244-51. PubMed ID: 26174662
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis B Virus DNA-Level Change is Associated With Tumor Recurrence in Patients With Resected Hepatitis B Virus Hepatocellular Carcinoma.
Cho WT; Yoo T; Lee JM; Lee JW; Kim H; Lee JS; Han SH
J Surg Res; 2024 Mar; 295():231-239. PubMed ID: 38041902
[TBL] [Abstract][Full Text] [Related]
33. Early and Late Recurrence of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Wang MD; Li C; Liang L; Xing H; Sun LY; Quan B; Wu H; Xu XF; Wu MC; Pawlik TM; Lau WY; Shen F; Yang T
Oncologist; 2020 Oct; 25(10):e1541-e1551. PubMed ID: 32472951
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B virus core-related antigen as a surrogate marker for covalently closed circular DNA.
Wong DK; Seto WK; Cheung KS; Chong CK; Huang FY; Fung J; Lai CL; Yuen MF
Liver Int; 2017 Jul; 37(7):995-1001. PubMed ID: 27992681
[TBL] [Abstract][Full Text] [Related]
35. Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients.
Laras A; Koskinas J; Dimou E; Kostamena A; Hadziyannis SJ
Hepatology; 2006 Sep; 44(3):694-702. PubMed ID: 16941694
[TBL] [Abstract][Full Text] [Related]
36. Research progress on detection methods for hepatitis B virus covalently closed circular DNA.
Sun F; Xia W; Ouyang Y
J Viral Hepat; 2023 May; 30(5):366-373. PubMed ID: 36751941
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic Value of Detection of Pregenomic RNA in Sera of Hepatitis B Virus-Infected Patients with Different Clinical Outcomes.
Lin N; Ye A; Lin J; Liu C; Huang J; Fu Y; Wu S; Xu S; Wang L; Ou Q
J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31723011
[TBL] [Abstract][Full Text] [Related]
38. Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine.
Bowden S; Locarnini S; Chang TT; Chao YC; Han KH; Gish RG; de Man RA; Yu M; Llamoso C; Tang H
World J Gastroenterol; 2015 Apr; 21(15):4644-51. PubMed ID: 25914474
[TBL] [Abstract][Full Text] [Related]
39. Nested real-time quantitative polymerase chain reaction assay for detection of hepatitis B virus covalently closed circular DNA.
Xu CH; Li ZS; Dai JY; Zhu HY; Yu JW; Lü SL
Chin Med J (Engl); 2011 May; 124(10):1513-6. PubMed ID: 21740808
[TBL] [Abstract][Full Text] [Related]
40. The intracellular HBV DNAs as novel and sensitive biomarkers for the clinical diagnosis of occult HBV infection in HBeAg negative hepatocellular carcinoma in China.
Wang H; Fang M; Gu X; Ji Q; Li D; Cheng SQ; Shen F; Gao CF
PLoS One; 2014; 9(9):e107162. PubMed ID: 25229710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
